Long-term treatment of pulmonary hypertension with aerosolized iloprost

European Respiratory Journal

Volumn 17, Issue 1, 2001, Pages 8-13

  Machherndl, S ^a   Kneussl, M ^a   Baumgartner, H ^a   Schneider, B ^a   Petkov, V ^a   Schenk, P ^a   Lang, I M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chronic vasodilator therapy; Ilomedin; Pulmonary hypertension

Indexed keywords

ILOPROST; OXYGEN; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; VASODILATOR AGENT;

ADOLESCENT; ADULT; AEROSOL; AGED; ARTERIAL OXYGEN SATURATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; EXERCISE TOLERANCE; FEMALE; HEART CATHETERIZATION; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HUMAN; LONG TERM CARE; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASODILATATION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AEROSOLS; AGED; BLOOD PRESSURE; CARDIAC OUTPUT; CHRONIC DISEASE; EPOPROSTENOL; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; OXYGEN; PROSPECTIVE STUDIES; PULMONARY CIRCULATION; PULMONARY EMBOLISM; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 0034949385     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.17100080     Document Type: Article

References (25)

1. Primary and thromboembolic pulmonary hypertension: A quantitative pathological study
2. Primary pulmonary hypertension: A histopathologic study of 80 cases
3. Primary pulmonary hypertension
4. Pulmonary hypertension: Mechanisms and treatment
5. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry
6. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension
7. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
8. Primary pulmonary hypertension: A pathologic study of the lung vessels in 156 clinically diagnosed cases
9. Long-term prostacyclin reduces pulmonary vascular resistance in severe primary pulmonary hypertension
10. Pulmonary capillaritis: A possible histologic form of acute pulmonary allograft rejection
11. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
12. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)
13. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin
14. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
15. Aerosolised prostacyclin in adult respiratory distress syndrome
16. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension
17. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue
18. Reduction of pulmonary vascular resistance with long term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
19. Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension
20. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial
21. Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost
22. Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension
23. A comparison of the acute haemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension
24. Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: A case series